Cargando…

Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors

Homologous recombination (HR) is a DNA double-strand break (DSB) repair pathway that utilizes a homologous template to fully repair the damaged DNA. HR is critical to maintain genome stability and to ensure genetic diversity during meiosis. A specialized class of enzymes known as recombinases facili...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelso, Andrew A., Waldvogel, Sarah M., Luthman, Adam J., Sehorn, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594099/
https://www.ncbi.nlm.nih.gov/pubmed/28936205
http://dx.doi.org/10.3389/fmicb.2017.01716
_version_ 1783263163117993984
author Kelso, Andrew A.
Waldvogel, Sarah M.
Luthman, Adam J.
Sehorn, Michael G.
author_facet Kelso, Andrew A.
Waldvogel, Sarah M.
Luthman, Adam J.
Sehorn, Michael G.
author_sort Kelso, Andrew A.
collection PubMed
description Homologous recombination (HR) is a DNA double-strand break (DSB) repair pathway that utilizes a homologous template to fully repair the damaged DNA. HR is critical to maintain genome stability and to ensure genetic diversity during meiosis. A specialized class of enzymes known as recombinases facilitate the exchange of genetic information between sister chromatids or homologous chromosomes with the help of numerous protein accessory factors. The majority of the HR machinery is highly conserved among eukaryotes. In many protozoan parasites, HR is an essential DSB repair pathway that allows these organisms to adapt to environmental conditions and evade host immune systems through genetic recombination. Therefore, small molecule inhibitors, capable of disrupting HR in protozoan parasites, represent potential therapeutic options. A number of small molecule inhibitors were identified that disrupt the activities of the human recombinase RAD51. Recent studies have examined the effect of two of these molecules on the Entamoeba recombinases. Here, we discuss the current understandings of HR in the protozoan parasites Trypanosoma, Leishmania, Plasmodium, and Entamoeba, and we review the small molecule inhibitors known to disrupt human RAD51 activity.
format Online
Article
Text
id pubmed-5594099
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55940992017-09-21 Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors Kelso, Andrew A. Waldvogel, Sarah M. Luthman, Adam J. Sehorn, Michael G. Front Microbiol Microbiology Homologous recombination (HR) is a DNA double-strand break (DSB) repair pathway that utilizes a homologous template to fully repair the damaged DNA. HR is critical to maintain genome stability and to ensure genetic diversity during meiosis. A specialized class of enzymes known as recombinases facilitate the exchange of genetic information between sister chromatids or homologous chromosomes with the help of numerous protein accessory factors. The majority of the HR machinery is highly conserved among eukaryotes. In many protozoan parasites, HR is an essential DSB repair pathway that allows these organisms to adapt to environmental conditions and evade host immune systems through genetic recombination. Therefore, small molecule inhibitors, capable of disrupting HR in protozoan parasites, represent potential therapeutic options. A number of small molecule inhibitors were identified that disrupt the activities of the human recombinase RAD51. Recent studies have examined the effect of two of these molecules on the Entamoeba recombinases. Here, we discuss the current understandings of HR in the protozoan parasites Trypanosoma, Leishmania, Plasmodium, and Entamoeba, and we review the small molecule inhibitors known to disrupt human RAD51 activity. Frontiers Media S.A. 2017-09-07 /pmc/articles/PMC5594099/ /pubmed/28936205 http://dx.doi.org/10.3389/fmicb.2017.01716 Text en Copyright © 2017 Kelso, Waldvogel, Luthman and Sehorn. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Kelso, Andrew A.
Waldvogel, Sarah M.
Luthman, Adam J.
Sehorn, Michael G.
Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors
title Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors
title_full Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors
title_fullStr Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors
title_full_unstemmed Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors
title_short Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors
title_sort homologous recombination in protozoan parasites and recombinase inhibitors
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594099/
https://www.ncbi.nlm.nih.gov/pubmed/28936205
http://dx.doi.org/10.3389/fmicb.2017.01716
work_keys_str_mv AT kelsoandrewa homologousrecombinationinprotozoanparasitesandrecombinaseinhibitors
AT waldvogelsarahm homologousrecombinationinprotozoanparasitesandrecombinaseinhibitors
AT luthmanadamj homologousrecombinationinprotozoanparasitesandrecombinaseinhibitors
AT sehornmichaelg homologousrecombinationinprotozoanparasitesandrecombinaseinhibitors